Comparative genomics allowed the identification of drug targets against human fungal pathogens
<p>Abstract</p> <p>Background</p> <p>The prevalence of invasive fungal infections (IFIs) has increased steadily worldwide in the last few decades. Particularly, there has been a global rise in the number of infections among immunosuppressed people. These patients presen...
Main Authors: | Martins Natalia F, Teixeira Marcus M, Kioshima Erika S, Abadio Ana Karina R, Maigret Bernard, Felipe Maria Sueli S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-01-01
|
Series: | BMC Genomics |
Online Access: | http://www.biomedcentral.com/1471-2164/12/75 |
Similar Items
-
Identification of New Antifungal Compounds Targeting Thioredoxin Reductase of Paracoccidioides Genus.
by: Ana Karina Rodrigues Abadio, et al.
Published: (2015-01-01) -
Carrier-Mediated Drug Uptake in Fungal Pathogens
by: Mónica Galocha, et al.
Published: (2020-11-01) -
Genomic Instability in Fungal Plant Pathogens
by: Shay Covo
Published: (2020-04-01) -
On Variant Discovery in Genomes of Fungal Plant Pathogens
by: Lizel Potgieter, et al.
Published: (2020-04-01) -
Comparative genomic analysis of human fungal pathogens causing paracoccidioidomycosis.
by: Christopher A Desjardins, et al.
Published: (2011-10-01)